Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)

Cornelis Smit,Roeland E. Wasmann,Marinus J. Wiezer,Hendricus P. A. van Dongen,Johan W. Mouton,Monika Brüggemann,Catherijne A. J. Knibbe

Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)

2020

Cornelis Smit
Roeland E. Wasmann
Marinus J. Wiezer
Hendricus P. A. van Dongen
Johan W. Mouton
Monika Brüggemann
Catherijne A. J. Knibbe

There was a mistake in the units of CL and Q, and in the parentheses of the formula for CL in the final model in Table 2. The corrected Table appears below.

Keywords:

Sampling (statistics)
Chemistry
Urology
Renal function
Tobramycin
Chromatography
Pharmaceutical sciences
Pharmacokinetics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations